Investigation of the efficacy and safety of a diindolylmethane-based drug in patients with cervical intraepithelial neoplasia grades 1-2 (CIN 1-2)

Autor:	Leonidova T.N. Leonidova T, Udut V.V. Udut, Suturina L.V. Suturina, Shamina I.V. Shamina, Kiselev V.I. Kiselev, Sukhikh G.T. Sukhikh, Tskhai V.B. Tskhai, Maltseva L.I. Maltseva L, Faculty for Advanced Training, Ordiyants I.M. Ordiyants I, Guryeva V.A. Guryeva, Muyzhnek E.L. Muyzhnek E, Evtushenko I.D. Evtushenko I, Kulagina N.V. Kulagina N, Bebneva T.N. Bebneva T, Radzinsky V.E. Radzinsky, Khasanov R.Sh. Khasanov R, Baranov A.N. Baranov A, Ao MiraxBioFarma, Moscow, Russia, Apolikhina I.A. Apolikhina I, Selivanov S.P. Selivanov, Karakhalis L.Yu. Karakhalis L, Ashrafyan L.A. Ashrafyan
Rok vydání:	2018
Předmět:	Drug Oncology medicine.medical_specialty business.industry media_common.quotation_subject Diindolylmethane General Medicine Cervical intraepithelial neoplasia medicine.disease Internal medicine Medicine In patient business media_common
Zdroj:	Akusherstvo i ginekologiia. :91-98
ISSN:	2412-5679
DOI:	10.18565/aig.2018.9.91-98
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6bd30dab8de82e7b971d5853393d4e5f https://doi.org/10.18565/aig.2018.9.91-98 Zobrazit plný text záznamu